Literature DB >> 1503755

Recombinant circle PCR and recombination PCR for site-specific mutagenesis without PCR product purification.

D H Jones1, S C Winistorfer.   

Abstract

Two simple methods for site-specific mutagenesis are described and compared. In each method, the PCR is used in two separate amplifications to mutate the site of interest and to add ends to one PCR product that are homologous to the ends of the other PCR product. In the first method, the two products are combined, denatured and reannealed prior to transformation of E. coli in order to form recombinant circles in vitro, while in the second method, the two linear products are co-transfected directly into E. coli without prior manipulation, resulting in transformation of E. coli with the recombinant of interest by recombination in vivo. Each PCR amplification uses a plasmid template that has been linearized by restriction enzyme digestion outside the region to be amplified. This permits use of unpurified PCR products in these two protocols and generation of the mutant of interest with no other enzymatic manipulation in vitro apart from PCR amplification. In each protocol greater than or equal to 50% of the resulting clones contained the mutation of interest without detected errors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1503755

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  15 in total

1.  The DDE motif in RAG-1 is contributed in trans to a single active site that catalyzes the nicking and transesterification steps of V(D)J recombination.

Authors:  P C Swanson
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Sensitivity of splice sites to antisense oligonucleotides in vivo.

Authors:  H Sierakowska; M J Sambade; D Schümperli; R Kole
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

3.  Identification and characterization of a gain-of-function RAG-1 mutant.

Authors:  Aleksei N Kriatchko; Dirk K Anderson; Patrick C Swanson
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

4.  Stable alteration of pre-mRNA splicing patterns by modified U7 small nuclear RNAs.

Authors:  L Gorman; D Suter; V Emerick; D Schümperli; R Kole
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

5.  Mapping by multifragment cloning in vivo.

Authors:  D L Marykwas; S E Passmore
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

6.  HMG-I/Y, a new c-Myc target gene and potential oncogene.

Authors:  L J Wood; M Mukherjee; C E Dolde; Y Xu; J F Maher; T E Bunton; J B Williams; L M Resar
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

7.  Ligand-binding domain of an α7-nicotinic receptor chimera and its complex with agonist.

Authors:  Shu-Xing Li; Sun Huang; Nina Bren; Kaori Noridomi; Cosma D Dellisanti; Steven M Sine; Lin Chen
Journal:  Nat Neurosci       Date:  2011-09-11       Impact factor: 24.884

8.  Method to Overcome Inefficiencies in Site-Directed Mutagenesis of A/T-Rich DNA.

Authors:  Samuel A DeCero; Christa H Winslow; Jenifer Coburn
Journal:  J Biomol Tech       Date:  2020-09

9.  Genetically modified L3,7 and L2 lipooligosaccharides from Neisseria meningitidis serogroup B confer a broad cross-bactericidal response.

Authors:  V Weynants; P Denoël; N Devos; D Janssens; C Feron; K Goraj; P Momin; D Monnom; C Tans; A Vandercammen; F Wauters; Jan T Poolman
Journal:  Infect Immun       Date:  2009-03-16       Impact factor: 3.441

10.  Malignant transformation of early lymphoid progenitors in mice expressing an activated Blk tyrosine kinase.

Authors:  S N Malek; D I Dordai; J Reim; H Dintzis; S Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.